Topics

Global and North America DNA and Gene Chip Market Status and Future Forecast 20132023 [Report Updated: 05012018] Prices from USD $2500

10:18 EST 3 Feb 2018 | BioPortfolio Reports

Summary

Key Content of Chapters Including and can be customized

Part 1:

Market Overview, Development, and Segment by Type, Application Region

Part 2:

Global Market by company, Type, Application Region

Part 3:

North America Market by company, Type, Application Region

Part 46:

Key Regions of North America Market by Type, Application

Part 7:

Company information, Sales, Cost, Margin etc.

Part 8:

Conclusion

Market Segment as follows:

By Region

Global North America, Europe, Asia etc.

North America United States, Canada, Mexico

Key Companies

AFFYMETRIX INC

AGILENT TECHNOLOGIES INC

BIOMIEUX SA

BIOMETRIX TECHNOLOGY INC

BIONEER CORP

CAPITALBIO CORP

EUROFINS MWG OPERON

GREINER BIOONE

ILLUMINA INC

LC SCIENCES

LIFEGEN TECHNOLOGIES

LIFE TECHNOLOGIES CORP

MACROGEN INC

MICROARRAYS INC

NGK INSULATORS LTD

ROCHE NIMBLEGEN INC

SIGMAALDRICH

Market by Type

Oligonucleotide DNA microarrays oDNA

Complementary DNA microarrays cDNA

Market by Application

Gene expression

Cancer diagnostics treatments

Drug discovery

Genetics

SNP analysis

Others

Original Article: Global and North America DNA and Gene Chip Market Status and Future Forecast 20132023 [Report Updated: 05012018] Prices from USD $2500

NEXT ARTICLE

More From BioPortfolio on "Global and North America DNA and Gene Chip Market Status and Future Forecast 20132023 [Report Updated: 05012018] Prices from USD $2500"

Quick Search

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...